A lymphokine activated killer (LAK) cell assay has been developed utilizing a clonogenic microassay in agar-containing capillaries with KB tumor goal cells. The assay avoids
![Expression Pathology Inc. (EPI) Biotechnology](https://www.expressionpathology.com/js/uploads/2021/04/express.jpg)
Expression Pathology Inc. (EPI) Biotechnology
Multiplex tissue proteomic assays using FFPE IHC analysis